1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Supporting Research Using the Resources from the Osteoarthritis Initiative (OAI) is sponsored by National Institutes of Health (NIH) / National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). This opportunity invites research grant applications focused on utilizing the Osteoarthritis Initiative (OAI) database, clinical data, and images.
It aims to expand the use of these resources for novel analyses, exploration of OA epidemiology and progression, and application of new technologies to biospecimens and genetic data.
Topics include the use of biospecimens to discover biochemical markers for early or progressive disease, integration of biospecimens with imaging and clinical data, and development of robust tools for automated image analysis for OA diagnosis and monitoring.
Get alerted about grants like this
Get emailed when new opportunities from “National Institutes of Health (NIH) / National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Investigators in the broader research community are invited to apply. Confirm the full requirements in the official notice before applying.
Applications for Supporting Research Using the Resources from the Osteoarthritis Initiative (OAI) are due January 26, 2028. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Supporting Research Using the Resources from the Osteoarthritis Initiative (OAI) is funded by National Institutes of Health (NIH) / National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
OMB's proposed rewrite of 2 CFR Part 200 would bar political appointees from deferring to peer reviewers and require senior-appointee sign-off on every discretionary grant. NIH new awards are already down about 34% in 2026. Here is what the merit-review changes actually say, how 'Gold Standard Science' becomes a scoring lever, why R1 universities are being written out of some solicitations, and what principal investigators and research offices should do before October 1.
Read articleNIH's June 1 omnibus reset added Direct-to-Phase II to the STTR program for the first time. The change compresses university spinouts' funding timeline from three years to fifteen months, but the 30% research-institution subaward, feasibility-evidence rules, and IP licensing mechanics are not yet sorted at most universities.
Read articleNIH committed $402 million across 601 multiyear-funded grants in the first eight months of FY 2026 — more than four times the pace of two years ago. The mechanism front-loads obligations into a single fiscal year, leaving less budget for new project starts and squeezing FY 2026 success rates. What researchers and institutions should be doing now.
Read article